NEW YORK, NY / ACCESSWIRE / April 8, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against CTI BioPharma Corp. ("CTI" or the "Company") (CTIC). The class action has ...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of CTI BioPharma Corp. securities (NASDAQ:CTIC) pursuant to and/or traceable to the Registration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback